CSI Market
Sign In | Register

Vir Biotechnology Inc (VIR) Annual Balance Sheets

Annual · GAAP · USD millions
Access VIR quarterly Balance Sheets →
The table below presents a historical view of Vir Biotechnology Inc's balance sheet, supporting analysis of financial position trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent232.19
Restricted Cash and Cash Equivalents, Current1.92
Marketable Securities, Current SH228.75
Cash & Short-term Investments461.00
Accounts receivable0.00
Other Current Assets6.08
Prepaid Expense And Other Assets Current45.14
Total Current Assets514.08
Equipment/Property/Plant Net55.62
Goodwill net16.94
Intangible Assets7.85
Long-term investments314.58
Other Assets, Noncurrent408.34
Equity Investment Current-
Operating Lease Right Of Use Asset62.10
Total Assets1,002.82
Liabilities
Accounts Payable, Current AC9.80
Accrued Liabilities, Current83.01
Other Liabilities, Current0.00
Deferred Revenue, Current DE0.00
Business Combination, Contingent Consideration, Liability, Current BU0.00
Total Current Liabilities92.82
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE0.00
Other liabilities, Noncurrent144.73
Operating Lease Liability Noncurrent89.05
Deferred Income Tax Liabilities Net-
Total Liabilities237.55
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,965.09
Retained Earnings / Accumulated Deficit-1,197.77
Other Equity-2.06
Common Stockholder's Equity765.28
Total Stockholder's Equity765.28
Liabilities & Stockholder's Equity1,002.82
4 historic quarters locked

Sign in to unlock the full Vir Biotechnology Inc balance sheet history.

Sign In Create Free Account

About Vir Biotechnology Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 23, 2026
  • Source: vir-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-010749

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License